SCHEMBL22739243

SCHEMBL22739243

C/C(C[C@@H](C)N(C)C(=O)c1ccc(Cl)c(Cl)c1)=N\N(C)CCNS(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.35
▸ HPGD P15428 3/20 0.35
▸ SCN9A Q15858 1/20 0.34
▸ TMEM97 Q5BJF2 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ GRN P28799 1/20 0.32
▸ SORT1 Q99523 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22739361 0.83 TSHR (0.39) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL22739234 0.71 TSHR (0.40) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL22727335 0.69 TSHR (0.44) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL22727569 0.67 TSHR (0.43) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL7964347 0.62 SCN9A (0.43) TSHRHPGDSCN9AKCNH2GRIN1
SCHEMBL11783170 0.61 TSHR (0.54) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL11782487 0.61 TSHR (0.50) TSHRHPGDSLC6A2SLC6A4SLC6A3
SCHEMBL2432947 0.60 SLC6A4 (0.44) HPGDSCN9ASLC6A4GRIN1GRIN2B
SCHEMBL2432944 0.60 SLC6A4 (0.44) HPGDSCN9ASLC6A4GRIN1GRIN2B
SCHEMBL6568396 0.60 TSHR (0.53) TSHRHPGDSCN9ASIGMAR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243142-A1 FUSED HETEROCYCLIC DERIVATIVES AS ANTIVIRAL AGENTS Janssen Sciences Ireland Unlimited Company (IE) 2020-12-03 — — WO disclosed
Send feedback